Spero Health - Indianapolis

Located in Lexington, KY, Spero Health - Indianapolis operates in KY's broader addiction-treatment market. The facility's programming is outpatient (Outpatient, MAT), not residential. What this page tries to do is frame the specific questions worth asking, which are rarely the ones that get asked first.

Care levels at Spero Health - Indianapolis

Spero Health - Indianapolis is an outpatient-focused program (Outpatient, MAT) — patients live at home or in sober living and attend treatment sessions. This level of care is clinically appropriate for mild-to-moderate substance use disorder, or for patients stepping down from residential. The level-of-care question is where a lot of misaligned placements happen — a patient who needs residential ends up in IOP, or vice versa. The protection is a clinical assessment outside the facility's admissions team.

Insurance and payment

Spero Health - Indianapolis accepts both Medicaid and commercial insurance, which is the broadest payer profile and typically correlates with programs that operate at scale across the economic spectrum. The facility also accepts TRICARE or military benefits. The uncomfortable truth about insurance at most treatment centers is that admissions staff and the utilization-review team sometimes have different understandings of what was promised. Written VOB forces those understandings into alignment.

Specialty programming

The facility's documented specialty programming includes: Adult women, Pregnant/postpartum women, Adult men. "Specialty track" is a marketing category often; it becomes a clinical category when specific clinicians deliver specific programming for a documented number of hours per week. Ask for those specifics.

Before you call

Questions that matter before admitting to Spero Health - Indianapolis: ASAM level of care (not the facility's category, the clinical level); written VOB; MAT policy. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation. The ones who answer those quickly are usually the ones worth considering. The ones who dodge are almost always worth skipping.